Neoantigen Cancer Vaccine Market Size is Projected to Reach $1.38 billion by 2030: Straits Research
October 26, 2023 15:00 ET
|
Straits Research
New York, United States, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Neoantigens that arise from cancer-specific mutations are an additional class of antigens that are desirable for therapeutic cancer...
Global Neoantigen Cancer Vaccine Research Report 2023: An $8.872 Billion Market by 2031 - Growing at a Staggering CAGR of 69.4%
September 27, 2023 04:28 ET
|
Research and Markets
Dublin, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The "Global Neoantigen Cancer Vaccine Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The global...
Global Cancer Vaccine Market & Clinical Trials Outlook 2028: Featuring Key Players AstraZeneca, BioNTech, Merck & Others
July 26, 2022 07:43 ET
|
Research and Markets
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Vaccine Market & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The global cancer...
Global Neoantigen Cancer Vaccine Market Report 2022: Focus on Approach, Line of Therapy, Type, Application, Treatment Strategy and Country-Wise Analysis
April 18, 2022 04:18 ET
|
Research and Markets
Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "Global Neoantigen Cancer Vaccine Market Analysis and Forecasts 2024-2031" report has been added to ResearchAndMarkets.com's offering. The neoantigen...
Global $1.75 Bn Neoantigen Cancer Vaccine Markets, 2020-2022 & 2023-2026
July 30, 2021 05:58 ET
|
Research and Markets
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "Global Neoantigen Cancer Vaccine Market, By Product, By Neoantigen Type, By Route of Administration, By Cell, By Technology, By Delivery Mechanism, By...